Safeplus International Holdings Ltd. (ACAI)

[sunspotter]

"your calculations would be called the "per share value of cash on hand" which of course has very little to do with the intrinsic value of the company"

In the case of most companies I would agree with you. However in the case of Biophan, just about all of the non-cash value resides in the Myotech CSS device, which has yet to have a development program outlined.

Indeed Biophan have never had any discussion with FDA about this device in spite of literally years of promises that commercialization was 18-24 months away. It never was, of course, in the same way that tomorrow never comes.

Now Biophan have stopped pretending that Myotech CSS will be available in any time frame. That would worry me if I were a Biophan shareholder.

"I see no personal reward from being in a position to say "I told you so""

Neither do I, but if during my pastime of investigating likely stocks for collapse due to (ahem) maladministration, then I'm not cold-hearted enough to leave innocent bystanders to the mercy of those who would tell them it's raining while they urinate in their ear.

But that's just me, as I've said before. And I do find I get useful tips from investors by posting on boards like these. For example via private email I have been sent from sources which would surprise some readers here, a fairly extensive record of regulation FD-busting emails from one Michael Weiner.

voldemort2001